Carl Washington, et al v. CVS Pharmacy, Inc.

  1. December 06, 2022

    9th Circ. Backs CVS' Win Over $121M Drug Overcharge Claim

    A panel of Ninth Circuit judges on Tuesday swiftly rejected arguments that lengthy jury instructions and excluded evidence had improperly sunk a $121 million lawsuit that claimed CVS' now-defunct discount program deliberately overcharged customers for generic drugs.

  2. November 15, 2022

    CVS Drug Buyers Face Skeptical 9th Circ. In $121M Retrial Bid

    A certified class of insured drug buyers urged the Ninth Circuit on Tuesday to order a new trial after losing claims CVS Pharmacy owes $121 million for overcharging on generic drugs, arguing the trial judge erred in limiting their theories of liability and issuing a lengthy jury instruction on third-party beneficiaries.

  3. January 28, 2022

    CVS Drug Buyers Ask 9th Circ. For Redo Of $121M Trial

    Legal errors by a California federal court during a June trial prejudiced a jury, leading it to clear CVS Pharmacy Inc. of claims that it overcharged insured drug buyers by more than $121 million for generic drugs, multiple buyer classes told the Ninth Circuit in an opening brief.